Influence of accepting basic antirheumatic therapy for ankylosing spondyloarthritis on the clinical course Covid-19

The article presents data from our ownstudies on the clinical course of COVID-19 in patientswith ankylosing spondylitis while receiving basic therapy. Patients were divided into groups:those who underwent COVID-19 against the background of basic therapy and without it. Theimpact of COVID-19 was compared with clinical symptoms, disease activity. According to theresults of the studies, a positive effect of basic antirheumatic therapy on the course ofcoronavirus infection in patients with ankylosing spondylitis was revealed.

Ҳали таржима қилинмаган